n-acetylcysteine as a glutathione precursor for schizophrenia in psychiatry: current therapeutic evidence and potential mechanisms of action The neuroprotective effects of N-acetylcysteine
The neuroprotective effects of N acetylcysteine in psychiatric and neurodegenerative disorders: From modulation of glutamatergic transmission to restoration of synaptic plasticity ScienceDirect Antipsychotic Augmentation With N Acetylcysteine for Patients With Schizophrenia Existing and potential therapeutic uses for N acetylcysteine: The need for conversion to intracellular glutathione for antioxidant benefits ScienceDirect Schizophrenia and Glutathione: A Challenging Story Full article: Targeting of NMDA receptors in new treatments for schizophrenia Item Glutathione precursor, N acetyl cysteine, improves mismatch negativity in schizophrenia patients Deakin University Figshare
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12




